Impact of MetaCalm on Stress of Healthy People With Acute Stress
Starting soon · Not applicable
Conditions studied: Adults, Acute Stress Reaction
In brief
This Open-Label, Non-Randomized Clinical Study involving 280 participants who will undergo a total participation of 6 hours.
Key facts
- Study ID
- NCT07507669
- Run by
- Metagenics, Inc.
- People needed
- 280
- Starts
- 2026-04-15
- Expected to finish
- 2026-08-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Providing written informed consent
- Males and females of at least 18 years old
- Obtaining a reference score of ≥ 30 on the STAI questionnaire (State-Trait Anxiety Inventory, short version, 10-item scale)
You may not qualify if…
- Being on anxiolytic and beta blocker treatment
- Individuals who use illicit or recreational drugs
- Having consumed adaptogen plants in one week prior to enrollment
- Participating in another clinical trial
- Patients diagnosed with cancer
- Allergic to any of the ingredients in this product
- Obtaining a reference score of less than 30 on the STAI questionnaire (State-Trait Anxiety Inventory, short version, 10-item scale)
Where it is running
- University of Molise — Campobasso, Italy
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.